The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Although the administration method seems ideal for prehospital use, the complexities of stroke assessment — including CT imaging and neurologist evaluation — still limit EMS adoption. Mechanical ...

A new report published in Brain Medicine reveals that a single dose of the drug Osanetant, administered shortly after a ...